GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MyunMoon Pharm Co Ltd (XKRX:017180) » Definitions » EV-to-FCF

MyunMoon Pharm Co (XKRX:017180) EV-to-FCF : -21.39 (As of Jan. 18, 2025)


View and export this data going back to 2008. Start your Free Trial

What is MyunMoon Pharm Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, MyunMoon Pharm Co's Enterprise Value is ₩150,019 Mil. MyunMoon Pharm Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-7,014 Mil. Therefore, MyunMoon Pharm Co's EV-to-FCF for today is -21.39.

The historical rank and industry rank for MyunMoon Pharm Co's EV-to-FCF or its related term are showing as below:

XKRX:017180' s EV-to-FCF Range Over the Past 10 Years
Min: -198.47   Med: -20.5   Max: 698.72
Current: -21.39

During the past 13 years, the highest EV-to-FCF of MyunMoon Pharm Co was 698.72. The lowest was -198.47. And the median was -20.50.

XKRX:017180's EV-to-FCF is ranked worse than
100% of 548 companies
in the Drug Manufacturers industry
Industry Median: 23.77 vs XKRX:017180: -21.39

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-01-18), MyunMoon Pharm Co's stock price is ₩1787.00. MyunMoon Pharm Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-226.000. Therefore, MyunMoon Pharm Co's PE Ratio (TTM) for today is At Loss.


MyunMoon Pharm Co EV-to-FCF Historical Data

The historical data trend for MyunMoon Pharm Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyunMoon Pharm Co EV-to-FCF Chart

MyunMoon Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.56 -17.53 497.90 49.89 -19.67

MyunMoon Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.15 -19.67 -17.85 -37.97 -23.00

Competitive Comparison of MyunMoon Pharm Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, MyunMoon Pharm Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MyunMoon Pharm Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MyunMoon Pharm Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where MyunMoon Pharm Co's EV-to-FCF falls into.



MyunMoon Pharm Co EV-to-FCF Calculation

MyunMoon Pharm Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=150018.541/-7013.505
=-21.39

MyunMoon Pharm Co's current Enterprise Value is ₩150,019 Mil.
MyunMoon Pharm Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-7,014 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MyunMoon Pharm Co  (XKRX:017180) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

MyunMoon Pharm Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1787.00/-226.000
=At Loss

MyunMoon Pharm Co's share price for today is ₩1787.00.
MyunMoon Pharm Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-226.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


MyunMoon Pharm Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of MyunMoon Pharm Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


MyunMoon Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
946-18 Dokok-Dong, Kangnam-ku, Seoul, KOR, 135-270
MyunMoon Pharm Co Ltd is a South Korea based company engages in the manufacture and sale of pharmaceutical products. Its products include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs, and others.

MyunMoon Pharm Co Headlines

No Headlines